Interleukin 15 (IL-15) is a novel cytokine with interleukin-2-like act
ivity. It is also a potent T-lymphocyte chemoattractant. Rheumatoid ar
thritis (RA) is a chronic inflammatory disease characterized by the pr
esence of activated T lymphocytes, macrophages and synoviocytes in the
synovial membrane. The mechanisms of T-cell activation in RA are curr
ently unclear. We report the presence of high concentrations of IL-15
in rheumatoid arthritis (RA) synovial fluid and have demonstrated its
expression in the synovial membrane lining layer by immunohistochemist
ry. RA synovial fluids were found to contain chemotactic activity, whi
ch was attributable in part to the presence of IL-15. Moreover, in a m
urine model, injection of recombinant IL-15 was found to induce a loca
l tissue inflammatory infiltrate consisting predominantly of T lymphoc
ytes. Synovial fluid T lymphocytes proliferate in response to IL-15, d
emonstrating that continued responsiveness to IL-15 is a feature of T
cells after entry into the synovial compartment, These data suggest th
at IL-15 can recruit and activate T lymphocytes into the synovial memb
rane, thereby contributing to RA pathogenesis.